You are here

• Home
• Therapy Areas
• Cardiovascular

• A Randomized, Open, Two-Way Cross-Over, Single-Centre, Phase I Study to Assess the Counter regulatory Response during Hypoglycaemia in Healthy Male Volunteers after a Single Oral Dose of AZD1656 Suspension in Comparison with Insulin Infusion

Disease

diabetes mellitus

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Nov 3, 2008

Study Name

D1020C00012

Study Id

D1020C00012

ClinicalTrials.gov ID

NCT00790153

Recruiting Status

Closed

Protocol Status

Not Available

Report

Jul 2, 2009

• D1020C00012.pdf (123 KB)

Page tools

• Print
• Bookmark this page